sparfloxacin has been researched along with Gonorrhea in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barlow, D; Gianotti, B; Jean, C; Moi, H; Morel, P; Phillips, I | 2 |
| Haraoka, M; Kobayashi, I; Nagafuji, T; Nakayama, H; Saika, T; Tanaka, M | 1 |
| Kanayama, A; Kobayashi, I; Mochida, O; Naito, S; Saika, T; Tanaka, M; Tunoe, H | 1 |
| Akasaka, S; Inatomi, H; Matsumoto, T; Muratani, T; Takahashi, K; Yamada, Y | 1 |
| Kanayama, A; Kobayashi, I; Naito, S; Nakayama, H; Nishiyama, T; Saika, T; Tanaka, M | 1 |
2 trial(s) available for sparfloxacin and Gonorrhea
| Article | Year |
|---|---|
Efficacy and safety of single oral dose sparfloxacin vs ciprofloxacin in acute gonococcal urethritis in males. A multicentre international study.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Fluoroquinolones; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Quinolones; Urethritis | 1995 |
Comparative efficacy and safety of single oral doses of sparfloxacin versus ciprofloxacin in the treatment of acute gonococcal urethritis in men.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Fluoroquinolones; Gonorrhea; Humans; International Cooperation; Male; Middle Aged; Quinolones; Urethritis | 1996 |
4 other study(ies) available for sparfloxacin and Gonorrhea
| Article | Year |
|---|---|
Analysis of quinolone resistance mechanisms in a sparfloxacin-resistant clinical isolate of Neisseria gonorrhoeae.
Topics: Adult; Anti-Infective Agents; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Polymerase Chain Reaction; Quinolones; Treatment Failure | 1998 |
Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Fluoroquinolones; Gemifloxacin; Gonorrhea; Humans; Levofloxacin; Naphthyridines; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin | 2000 |
Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.
Topics: Adult; Anti-Infective Agents; Aztreonam; Cefdinir; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Gonorrhea; Humans; Japan; Male; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Neisseria gonorrhoeae; Roxithromycin; Spectinomycin; Urethritis | 2001 |
Comparison of Neisseria gonorrhoeae isolates from the genital tract and pharynx of two gonorrhea patients.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Genital Diseases, Male; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharyngeal Diseases; Pharynx; Spectinomycin; Sulbactam; Urethra | 2001 |